Stem Cells and Bone Tissue Engineering

Xueqin Gao,Joseph J. Ruzbarsky,Jonathan E. Layne,Xiang Xiao,Johnny Huard
DOI: https://doi.org/10.3390/life14030287
2024-02-21
Life
Abstract:Segmental bone defects that are caused by trauma, infection, tumor resection, or osteoporotic fractures present significant surgical treatment challenges. Host bone autograft is considered the gold standard for restoring function but comes with the cost of harvest site comorbidity. Allograft bone is a secondary option but has its own limitations in the incorporation with the host bone as well as its cost. Therefore, developing new bone tissue engineering strategies to treat bone defects is critically needed. In the past three decades, the use of stem cells that are delivered with different scaffolds or growth factors for bone tissue engineering has made tremendous progress. Many varieties of stem cells have been isolated from different tissues for use in bone tissue engineering. This review summarizes the progress in using different postnatal stem cells, including bone marrow mesenchymal stem cells, muscle-derived stem cells, adipose-derived stem cells, dental pulp stem cells/periodontal ligament stem cells, periosteum stem cells, umbilical cord-derived stem cells, peripheral blood stem cells, urine-derived stem cells, stem cells from apical papilla, and induced pluripotent stem cells, for bone tissue engineering and repair. This review also summarizes the progress using exosomes or extracellular vesicles that are delivered with various scaffolds for bone repair. The advantages and disadvantages of each type of stem cell are also discussed and explained in detail. It is hoped that in the future, these preclinical results will translate into new regenerative therapies for bone defect repair.
biology
What problem does this paper attempt to address?
The paper is primarily dedicated to addressing the clinical treatment challenges posed by segmental bone defects caused by trauma, infection, tumor resection, or osteoporotic fractures. Currently, autologous bone grafting is considered the gold standard for functional restoration, but it has the issue of complications at the donor site. Allogeneic bone grafting, as a secondary option, also faces problems such as poor integration with the host bone and high costs. Therefore, developing new bone tissue engineering techniques to treat bone defects is of great significance. The paper reviews the progress in bone tissue engineering over the past 30 years using stem cells from different sources (such as bone marrow mesenchymal stem cells, myogenic stem cells, adipose-derived stem cells, etc.) and discusses in detail the advantages and disadvantages of each type of stem cell. Additionally, the paper explores the research progress on using exosomes or extracellular vesicles combined with various scaffolds for bone repair. Researchers hope that these preclinical results can be translated into new regenerative therapies for bone defect repair in the future.